Clinicopathologic and Prognostic Differences between Three Different Age Groups (Child/Adolescent, Young Adults, and Adults) of Colorectal Cancer Patients: A Multicentre Study.


Journal

Oncology research and treatment
ISSN: 2296-5262
Titre abrégé: Oncol Res Treat
Pays: Switzerland
ID NLM: 101627692

Informations de publication

Date de publication:
2019
Historique:
received: 26 02 2018
accepted: 13 07 2019
pubmed: 23 8 2019
medline: 8 2 2020
entrez: 23 8 2019
Statut: ppublish

Résumé

Colorectal cancer (CRC) is a rare disease amongst children and adolescents. Previous studies have reported a number of differences between children/adolescents, young adults, and adult patients with CRC. However, none of these studies compared these age groups according to their clinicopathologic and prognostic characteristics. In the current study, we compare these three age groups. A total of 173 (1.1% of 15,654 patients) young CRC patients (≤25 years) were included in the study. As a control group, 237 adult CRC patients (>25 years) were also included. Patients were divided into three age groups: child/adolescent (10-19 years), young adult (20-25 years), and adult (>25 years). Statistical differences amongst the three groups in terms of gender (p = 0.446), family history (p = 0.578), symptoms of presentation (p = 0.306), and interval between initiation of symptoms and diagnosis (p = 0.710) could not be demonstrated. Whilst abdominal pain (p < 0.001) and vomiting (p = 0.002) were less common in young adults than in other groups, rectal bleeding and changes in bowel habits were relatively less common in adolescents than in other groups. Rectal localisation (p = 0.035), mucinous adenocarcinoma (p < 0.001), and a poorly differentiated histologic subtype (p < 0.001) were less common in the adult group than in other groups. The percentage of patients with metastasis and sites of metastasis (e.g., peritoneum and lung) differed between groups. The median overall survival was 32.6 months in the adolescent group, 57.8 months in the young adult group and was not reached in the adult group (p = 0.022). The median event-free survival of the adolescent, young adult, and adult groups was 29.0, 29.9, and 61.6 months, respectively (p = 0.003). CRC patients of different age groups present different clinicopathologic and prognostic characteristics. Clinicians should be aware of and manage the disease according to these differences.

Sections du résumé

BACKGROUND BACKGROUND
Colorectal cancer (CRC) is a rare disease amongst children and adolescents. Previous studies have reported a number of differences between children/adolescents, young adults, and adult patients with CRC. However, none of these studies compared these age groups according to their clinicopathologic and prognostic characteristics. In the current study, we compare these three age groups.
METHODS METHODS
A total of 173 (1.1% of 15,654 patients) young CRC patients (≤25 years) were included in the study. As a control group, 237 adult CRC patients (>25 years) were also included. Patients were divided into three age groups: child/adolescent (10-19 years), young adult (20-25 years), and adult (>25 years).
RESULTS RESULTS
Statistical differences amongst the three groups in terms of gender (p = 0.446), family history (p = 0.578), symptoms of presentation (p = 0.306), and interval between initiation of symptoms and diagnosis (p = 0.710) could not be demonstrated. Whilst abdominal pain (p < 0.001) and vomiting (p = 0.002) were less common in young adults than in other groups, rectal bleeding and changes in bowel habits were relatively less common in adolescents than in other groups. Rectal localisation (p = 0.035), mucinous adenocarcinoma (p < 0.001), and a poorly differentiated histologic subtype (p < 0.001) were less common in the adult group than in other groups. The percentage of patients with metastasis and sites of metastasis (e.g., peritoneum and lung) differed between groups. The median overall survival was 32.6 months in the adolescent group, 57.8 months in the young adult group and was not reached in the adult group (p = 0.022). The median event-free survival of the adolescent, young adult, and adult groups was 29.0, 29.9, and 61.6 months, respectively (p = 0.003).
CONCLUSIONS CONCLUSIONS
CRC patients of different age groups present different clinicopathologic and prognostic characteristics. Clinicians should be aware of and manage the disease according to these differences.

Identifiants

pubmed: 31437835
pii: 000502120
doi: 10.1159/000502120
doi:

Types de publication

Comparative Study Journal Article Multicenter Study

Langues

eng

Sous-ensembles de citation

IM

Pagination

516-522

Informations de copyright

© 2019 S. Karger AG, Basel.

Auteurs

Muhammet Ali Kaplan (MA)

Department of Medical Oncology, Dicle University Faculty of Medicine, Diyarbakir, Turkey, drmalikaplan@hotmail.com.

Sukru Ozaydin (S)

Department of Medical Oncology, Gulhane Education and Research Hospital, Ankara, Turkey.

Halis Yerlikaya (H)

Department of Medical Oncology, Dicle University Faculty of Medicine, Diyarbakir, Turkey.

Mustafa Karaagac (M)

Department of Medical Oncology, Konya Numune Training and Research Hospital, Konya, Turkey.

Mahmut Gumus (M)

Department of Medical Oncology, Faculty of Medicine, Medeniyet University, Istanbul, Turkey.

Timucin Cil (T)

Department of Medical Oncology, Adana Numune Education and Research Hospital, Adana, Turkey.

Ülkü Yalcintas Arslan (Ü)

Department of Medical Oncology, Ankara Oncology Training and Research Hospital, Ankara, Turkey.

Nuriye Ozdemir (N)

Department of Medical Oncology, Ankara Numune Education and Research Hospital, Ankara, Turkey.

Abdullah Sakin (A)

Department of Medical Oncology, Okmeydani Education and Research Hospital, Ankara, Turkey.

Mehmet Bilici (M)

Department of Medical Oncology, Atatürk University, Erzurum, Turkey.

Dogan Koca (D)

Department of Medical Oncology, Kocaeli Medikal Park Hospital, Kocaeli, Turkey.

Mukremin Uysal (M)

Department of Medical Oncology, Afyon Kocatepe University, Afyonkarahisar, Turkey.

Faysal Dane (F)

Department of Medical Oncology, Medical Oncology, Marmara University, Istanbul, Turkey.

Özlem Nuray Sever (ÖN)

Department of Medical Oncology, Gaziantep University Faculty of Medicine, Gaziantep, Turkey.

Mehmet Metin Seker (MM)

Medical Oncology Department, Cumhuriyet University Faculty of Medicine, Sivas, Turkey.

Zeynep Oruc Seker (Z)

Department of Medical Oncology, Dicle University Faculty of Medicine, Diyarbakir, Turkey.

Mehmet Fatih Can (MF)

Department of Medical Oncology, Gulhane Education and Research Hospital, Ankara, Turkey.

Caglayan Geredeli (C)

Department of Medical Oncology, Konya Numune Training and Research Hospital, Konya, Turkey.

Asude Aksoy (A)

Department of Medical Oncology, Faculty of Medicine, Fırat University, Malatya, Turkey.

Keziban Nur Pilanci (KN)

Department of Medical Oncology, Bilim University, Istanbul, Turkey.

Turkan Ozturk Topcu (T)

Department of Medical Oncology, Karadeniz Technical University School of Medicine, Trabzon, Turkey.

Abdurrahman Isikdogan (A)

Department of Medical Oncology, Dicle University Faculty of Medicine, Diyarbakir, Turkey.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH